Medical Economics Pulse

30: Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and CVD Outcomes

4 min · 24 sep 2025
aflevering 30: Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and CVD Outcomes artwork

Beschrijving

In this episode of the Weekly Dose podcast by Patient Care Online, we review recent studies on key clinical topics: the heightened risk of depression after chronic illness diagnosis, the safety of vaginal estradiol for women with prior stroke, the approval of generic liraglutide for obesity, the potential cancer risk reduction with GLP-1 therapies, and cardiovascular benefits of semaglutide in patients with obesity. The episode highlights important findings and their implications for clinical practice, offering health care professionals timely updates across mental health, women’s health, obesity management, cancer prevention, and cardiovascular care.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Medical Economics Pulse community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

28 afleveringen

aflevering 30: Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and CVD Outcomes artwork

30: Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and CVD Outcomes

In this episode of the Weekly Dose podcast by Patient Care Online, we review recent studies on key clinical topics: the heightened risk of depression after chronic illness diagnosis, the safety of vaginal estradiol for women with prior stroke, the approval of generic liraglutide for obesity, the potential cancer risk reduction with GLP-1 therapies, and cardiovascular benefits of semaglutide in patients with obesity. The episode highlights important findings and their implications for clinical practice, offering health care professionals timely updates across mental health, women’s health, obesity management, cancer prevention, and cardiovascular care.

24 sep 20254 min